Compare Magna International Inc. Common Stock (MGA) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Magna International Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Magna International Inc. Common Stock trades at $64.06 (market cap $17.04B), while Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B). The key difference: Magna International Inc. Common Stock is far larger — about 9.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Magna International Inc. Common Stock pays a 3.1% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Magna International Inc. Common Stock for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| MGA | NUVB | |
|---|---|---|
Market Cap | $17.04B | $1.74B |
Volume | 1,523,784 | 9,289,619 |
Sector | Consumer Cyclical | Health |
52-Week High | $73.05 | $9.54 |
52-Week Low | $43.54 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $22.08B | $1.33B |
Dividend Yield | 3.1% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Magna International Inc. Common Stock
Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
